• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2024 年 IUPHAR/BPS 药理学指南。

The IUPHAR/BPS Guide to PHARMACOLOGY in 2024.

机构信息

Centre for Discovery Brain Science, Deanery of Biomedical Sciences, University of Edinburgh, Edinburgh EH8 9XD, UK.

School of Life Sciences, University of Nottingham Medical School, Nottingham NG7 2UH, UK.

出版信息

Nucleic Acids Res. 2024 Jan 5;52(D1):D1438-D1449. doi: 10.1093/nar/gkad944.

DOI:10.1093/nar/gkad944
PMID:37897341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10767925/
Abstract

The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb; https://www.guidetopharmacology.org) is an open-access, expert-curated, online database that provides succinct overviews and key references for pharmacological targets and their recommended experimental ligands. It includes over 3039 protein targets and 12 163 ligand molecules, including approved drugs, small molecules, peptides and antibodies. Here, we report recent developments to the resource and describe expansion in content over the six database releases made during the last two years. The database update section of this paper focuses on two areas relating to important global health challenges. The first, SARS-CoV-2 COVID-19, remains a major concern and we describe our efforts to expand the database to include a new family of coronavirus proteins. The second area is antimicrobial resistance, for which we have extended our coverage of antibacterials in partnership with AntibioticDB, a collaboration that has continued through support from GARDP. We discuss other areas of curation and also focus on our external links to resources such as PubChem that bring important synergies to the resources.

摘要

IUPHAR/BPS 药理学指南(GtoPdb;https://www.guidetopharmacology.org)是一个开放获取的、专家编辑的在线数据库,为药理学靶点及其推荐的实验配体提供简洁的概述和关键参考。它包含超过 3039 个蛋白质靶点和 12163 个配体分子,包括已批准的药物、小分子、肽和抗体。在这里,我们报告了该资源的最新进展,并描述了在过去两年中进行的六次数据库更新中内容的扩展。本文数据库更新部分重点介绍了与两个重要的全球健康挑战相关的两个领域。第一个是 SARS-CoV-2 COVID-19,仍然是一个主要关注点,我们描述了我们努力扩展数据库以包括冠状病毒蛋白的一个新家族。第二个领域是抗菌素耐药性,为此我们与 AntibioticDB 合作扩展了抗菌药物的覆盖范围,该合作通过 GARDP 的支持得以延续。我们讨论了其他编辑领域,并重点介绍了我们与 PubChem 等资源的外部链接,这些链接为资源带来了重要的协同作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/88ca752e00e6/gkad944fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/c57e039be36b/gkad944figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/8e7866b6adab/gkad944fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/9fb96e438155/gkad944fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/ab12b344d119/gkad944fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/4188cd55ec17/gkad944fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/88ca752e00e6/gkad944fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/c57e039be36b/gkad944figgra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/8e7866b6adab/gkad944fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/9fb96e438155/gkad944fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/ab12b344d119/gkad944fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/4188cd55ec17/gkad944fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9da6/10767925/88ca752e00e6/gkad944fig5.jpg

相似文献

1
The IUPHAR/BPS Guide to PHARMACOLOGY in 2024.2024 年 IUPHAR/BPS 药理学指南。
Nucleic Acids Res. 2024 Jan 5;52(D1):D1438-D1449. doi: 10.1093/nar/gkad944.
2
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials.2022 年 IUPHAR/BPS 药理学指南:为 COVID-19、疟疾和抗菌药物药物治疗学。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294. doi: 10.1093/nar/gkab1010.
3
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.国际药理学联合会/英国药理学学会药物靶点和配体百科全书:一个由专家驱动的药物靶点和配体知识库。
Nucleic Acids Res. 2014 Jan;42(Database issue):D1098-106. doi: 10.1093/nar/gkt1143. Epub 2013 Nov 14.
4
The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.《2016年IUPHAR/BPS药理学指南:迈向1300个蛋白质靶点与6000种配体之间的精准定量相互作用》
Nucleic Acids Res. 2016 Jan 4;44(D1):D1054-68. doi: 10.1093/nar/gkv1037. Epub 2015 Oct 12.
5
The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY.2020 年国际药理学联合会/英国药理学学会药物学指南:扩充免疫药理学内容并推出国际药理学联合会/MMV 疟疾药物学指南。
Nucleic Acids Res. 2020 Jan 8;48(D1):D1006-D1021. doi: 10.1093/nar/gkz951.
6
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南:更新和扩展,以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.
7
The Concise Guide to PHARMACOLOGY 2013/14: overview.《2013/14药理学简明指南》:概述
Br J Pharmacol. 2013 Dec;170(8):1449-58. doi: 10.1111/bph.12444.
8
Accessing Expert-Curated Pharmacological Data in the IUPHAR/BPS Guide to PHARMACOLOGY.在《IUPHAR/BPS药理学指南》中获取专家整理的药理学数据。
Curr Protoc Bioinformatics. 2018 Mar;61(1):1.34.1-1.34.46. doi: 10.1002/cpbi.46.
9
The Concise Guide to PHARMACOLOGY 2015/16: Overview.《2015/16药理学简明指南:概述》
Br J Pharmacol. 2015 Dec;172(24):5729-43. doi: 10.1111/bph.13347.
10
The Concise Guide to PHARMACOLOGY 2015/16: Transporters.《2015/16 药理学简明指南:转运体》
Br J Pharmacol. 2015 Dec;172(24):6110-202. doi: 10.1111/bph.13355.

引用本文的文献

1
Discovery of clocinizine as a potential oral drug against Schistosoma mansoni infection.发现氯环嗪作为一种潜在的抗曼氏血吸虫感染的口服药物。
Sci Rep. 2025 Aug 21;15(1):30816. doi: 10.1038/s41598-025-89434-x.
2
SCOPE: Revealing Hidden Mechanisms in Phenotypic Screens Through Target and Pathway Enrichment.范围:通过靶点和通路富集揭示表型筛选中的隐藏机制。
bioRxiv. 2025 Jul 14:2025.07.11.664427. doi: 10.1101/2025.07.11.664427.
3
Spider venom peptides with unique fold selectively block Shaker-type potassium channels.具有独特折叠结构的蜘蛛毒液肽可选择性阻断Shaker型钾通道。

本文引用的文献

1
How many kinases are druggable? A review of our current understanding.有多少激酶可成药?对我们目前认识的综述。
Biochem J. 2023 Aug 30;480(16):1331-1363. doi: 10.1042/BCJ20220217.
2
DECIMER.ai: an open platform for automated optical chemical structure identification, segmentation and recognition in scientific publications.DECIMER.ai:一个用于科学出版物中光学化学结构自动识别、分割和识别的开放平台。
Nat Commun. 2023 Aug 19;14(1):5045. doi: 10.1038/s41467-023-40782-0.
3
Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts.
Cell Mol Life Sci. 2025 Aug 8;82(1):300. doi: 10.1007/s00018-025-05778-7.
4
Addressing Immune Response Dysfunction in an Integrated Approach for Testing and Assessment for Non-Genotoxic Carcinogens in Humans: A Targeted Analysis.以综合方法应对人类非遗传毒性致癌物检测与评估中的免疫反应功能障碍:靶向分析
Int J Mol Sci. 2025 Jun 30;26(13):6310. doi: 10.3390/ijms26136310.
5
InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs.InterPAD是一个关于植物化学物质与抗癌药物之间药物相互作用的数据库。
Sci Rep. 2025 Jul 9;15(1):24616. doi: 10.1038/s41598-025-10240-6.
6
Structural insights into GPCR signaling activated by peptide ligands: from molecular mechanism to therapeutic application.肽配体激活的G蛋白偶联受体信号转导的结构见解:从分子机制到治疗应用
Exp Mol Med. 2025 Jul 8. doi: 10.1038/s12276-025-01497-y.
7
Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.β受体阻滞剂通过调节神经免疫肿瘤轴延长前列腺癌患者对雄激素剥夺疗法的反应。
J Transl Med. 2025 Jun 17;23(1):672. doi: 10.1186/s12967-025-06644-7.
8
RIDDEN: Data-driven inference of receptor activity from transcriptomic data.RIDDEN:基于转录组数据的受体活性数据驱动推理
PLoS Comput Biol. 2025 Jun 16;21(6):e1013188. doi: 10.1371/journal.pcbi.1013188. eCollection 2025 Jun.
9
The cell-surface shared proteome of astrocytes and neurons and the molecular foundations of their multicellular interactions.星形胶质细胞和神经元的细胞表面共享蛋白质组及其多细胞相互作用的分子基础。
Neuron. 2025 Jun 5. doi: 10.1016/j.neuron.2025.05.019.
10
First-in-human safety, tolerability, pharmacokinetics and pilot food-effect study of the candidate antimalarial compound MMV367.候选抗疟化合物MMV367的首次人体安全性、耐受性、药代动力学及初步食物效应研究。
Br J Clin Pharmacol. 2025 Jun;91(6):1821-1833. doi: 10.1111/bcp.70000.
核心线粒体基因在 SARS-CoV-2 感染啮齿动物和人类宿主时被下调。
Sci Transl Med. 2023 Aug 9;15(708):eabq1533. doi: 10.1126/scitranslmed.abq1533.
4
Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38.疟疾药理学的进展和 MALARIA PHARMACOLOGY 在线指南:国际药理学联合会评论 38.
Br J Pharmacol. 2023 Aug;180(15):1899-1929. doi: 10.1111/bph.16144. Epub 2023 Jun 10.
5
Therapeutic strategies for COVID-19: progress and lessons learned.COVID-19 的治疗策略:进展与经验教训。
Nat Rev Drug Discov. 2023 Jun;22(6):449-475. doi: 10.1038/s41573-023-00672-y. Epub 2023 Apr 19.
6
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
7
Chemoinformatics and artificial intelligence colloquium: progress and challenges in developing bioactive compounds.化学信息学与人工智能研讨会:生物活性化合物开发的进展与挑战
J Cheminform. 2022 Dec 2;14(1):82. doi: 10.1186/s13321-022-00661-0.
8
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
9
GPCRdb in 2023: state-specific structure models using AlphaFold2 and new ligand resources.2023 年的 GPCRdb:使用 AlphaFold2 和新配体资源的特定状态结构模型。
Nucleic Acids Res. 2023 Jan 6;51(D1):D395-D402. doi: 10.1093/nar/gkac1013.
10
PubChem 2023 update.PubChem 2023 更新。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1373-D1380. doi: 10.1093/nar/gkac956.